Amaranthus spinosus is a medicinal plant used in traditional medicine to treat several diseases including diabetes and its complications. The aim of this study was to prove the safety of the plant in animal health.
Methods
The dry extract was obtained following the hydroethanolic extraction of A. spinosus roots. The cytotoxicity was evaluated in vitro by incubating Artemia salina larvae with the extract for 24 h. In vivo toxicity was assessed in Sprague Dawley rats. A single dose of 5000 mg/kg bw of extract was administered orally to female rats in acute toxicity and observed for 14 days for mortality and signs of toxicity. In subchronic toxicity, extract doses of 500 and 1000 mg/kg bw were administered orally to male and female rats for 28 consecutive days and observed for previous signs. Body weight was recorded daily and blood glucose levels every week. On day 29, blood was collected for biochemical and hematological studies. Organs were then exised for gross autopsy and histopathological examination.
Results
The in vitro study showed that the extract had a LC50 = 1.178 mg/mL in larvae and was considered to be non-cytotoxic. Oral administration of extract at a single dose of 5000 mg/kg bw did not cause any mortality or sign of toxicity in gross necropsy. In subchronic oral toxicity, repeated doses of 500 and 1000 mg/kg bw of extract, did not also cause any mortality or significant change in body weight, relative weight of vital organs. Furthermore, hematological and biochemical parameters and histopathological examination did not show any significant change. The observed decrease in blood glucose levels did not correlate with organ damage and supports the safety of the plant. However, the reduction of LDL-cholesterol has shown that the extract can prevent cardiovascular disease.
Conclusions
This finding demonstrated that A. spinosus root is non-toxic with a LD50 > 5000 mg/kg bw. Thus, the extract can be used for cutaneous and subchronic oral administration at doses ≤ 1000 mg/kg bw. However, further studies such as embryo/fetotoxicity, genotoxicity and neurotoxicity will be needed to prove the safety of chronic administration of the extract in patients and fetuses.
Hinweise
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
ALAT,
alanine aminotransferase
AS
Amaranthus spinosus
ASAT
Aspartate aminotransferase
ATC method
Acute toxicity class method
CPK
Creatinine phosphokinase
EDTA
Ethylenediaminetetraacetic acid
ɣ-GT
ɣ-glutamyltranspeptidase
HCT
Hematocrit
HDL-C
High-density lipoprotein cholesterol
HGB
Hemoglobin
LC50
Lethal concentration at 50%
LD50
Lethal dose at 50%
LDL-C
Low-density lipoprotein cholesterol
MCH
Mean corpuscular hemoglobin
MCHC
Mean corpuscular hemoglobin concentration
MCV
Mean corpuscular volume
OECD
Organization for Economic Co-operation and Development
PLT
Platelets
RBC
Red blood cells
SD
Sprague Dawley
SEM
Standard error of mean
TC
Total cholesterol
TG
Triglycerides
WBC
White blood cells
Introduction
Amaranthus spinosus L., commonly called spiny amaranth is a medicinal plant from Amaranthaceae family and height approximately 0.3 to 0.8 m. This annual monoecious herb is a nitrophile, generally grows around roads, on cultivated lands and gardens [1].
Spiny amaranth has considerable pharmacological properties. In traditional medicine, the plant is used as a diuretic, analgesic, antipyretic, against leprosy, bronchitis and laxative [2]. In Togo, the whole plant is used to produce soap and the roots to treat traditionally diabetes, stomach aches, and chronic infections in children [3]. Scientific studies have reported anti-cancer [4], antimicrobial [5], antimalarial [6], antipyretic [7], analgesic [8], anti-inflammatory [9], antioxidant [10], anti-diabetic [11], hepatoprotective [12], bronchodilator [13], and anxiolytic [14] activities of A. spinosus. Despite the widespread use of the plant, there is not enough information on its safety in animal health.
Anzeige
Previous studies on the subchronic toxicity of A. spinosus involved whole plant extracts and did not extend to their impacts on organs in animals [15, 16]. Furthermore, the studies which aim specifically to evaluate the cytotoxicity and the histopathological impact of the dried hydroethanolic extract of the roots of A. spinosus have not yet been undertaken.
The contribution of this study was then to determine the histopathological impact of the dried hydroethanolic extract of A. spinosus and its safety in animal health for cutaneous and oral administration. The objectives were to evaluate the safety of the extract in acute cytotoxicity in Artemia salina larvae and in acute and 28-day subchronic oral toxicities in Sprague Dawley rats.
Materials and methods
Chemicals and reagents
Serum urea, creatinine, creatine phosphokinase (CPK), transaminases (ASAT, ALAT), ɣ-glutamyltranspeptidase, triglycerides, total cholesterol, HDL–cholesterol were estimated using Cypress diagnostics reagent kits. Solvents used for hematoxylin-eosin staining in the histopathological study were also Cypress diagnostics. URIT–5160 Auto Hematology Analyzer reagents were URIT (URIT Medical Electronic CO., LTD). The dried hydroethanolic extract of A. spinosus roots was prepared locally.
Plant materials
Fresh roots of Amaranthus spinosus L. were collected in Dzagble (Lome) and has been identified in Laboratory of Botany and Plant Ecology of Faculty of Science, University of Lome. Voucher specimen was deposited under number 15516TOGO at the herbarium for reference. Roots were cut into small pieces and dried at the temperature of 20 ± 2 °C in safe from light for two weeks before reducing in powder.
Anzeige
Extract preparation
400 g of the powder of A. spinosus root were macerated in 4 L of water-ethanol mixture (50:50) for 72 h, then filtered through Whatman filter paper (Ø 150 mm). The filtrate was evaporated to dryness at a temperature of 45 °C under vacuum using a rotary evaporator Buchi type, Germany. The extraction yield was 18.15 % and the dried hydroethanolic extract obtained was stored at a temperature of 4 ± 2 °C for tests. This choice of extract was based on the use of hydroalcoholic maceration of the roots of A. spinosus in traditional medicine.
Artemia salina eggs
The eggs of Artemia salina were provided by the Laboratory of Toxicology of Faculty of Health Sciences, University of Lome. They were kept at a temperature of 4 ± 2 °C.
Animals
Male and female Sprague Dawley (SD) rats weighing 150 ± 15 g were used for in vivo studies. Animals were provided by the Animal Physiology Laboratory of Faculty of Sciences, University of Lome. They were housed divided by sex in cages under standard environmental conditions with free access to food and water ad libitum. Animal studies were carried out in accordance with the institutional guidelines of the Laboratory of Animal Physiology, University of Lome, registered under number 001/2012/CB-FDS-UL.
In vitro cytotoxicity
The safety of the extract was evaluated in brine shrimp larvae (Artemia salina) for 24 h in order to determine the cytotoxicity by contact of A. spinosus roots. The method is based on the survival of larvae in contact with the chemical [17]. The test was carried out by incubating 500 mg of the eggs of Artemia salina in 500 mL of seawater for 48 h at a temperature of 28 ± 2 °C with continuous agitation. After incubation, 16 mobile larvae from hatching eggs were incubated for 24 h with 2.0 mL of A. spinosus extract prepared in seawater (25; 12.5; 6.25; 3.13; 1.56; 0.78; 0.39; 0.20; 0.10 and 0.05 mg/mL). At the end, mobile larvae (surviving) were counted. The number of deaths was deduced and then analysed to determine the toxic concentration. Controls were carried out with seawater only. Larvae are considered viable for a mortality rate < 15 % in controls. n = 3. Mousseux scale [18] was used to compare the cytotoxicity of the extract:
The acute oral toxicity of A. spinosus root extract was conducted in accordance with Organization for Economic Co-operation and Development (OECD) guidelines, Test No. 423, using acute toxicity class method (ATC method) [19]. This evaluation permits to determine the 50 % lethal dose (LD50) of the extract. A single dose of 5000 mg/kg bw of A. spinosus extract was administrated orally to 3 female rats (180 ± 5 g) prior fasted one by one in 24 h interval. Thus, rats were individually observed for first 30 min. A special attention has given during the first 4 h and periodically observation of the first 24 h before observed daily for a total of 14 days for mortality, signs of gross toxicity or behavioral changes. The body weights of rats were recorded before and weekly. On day 15 of the end of experiment, rats were sacrificed by cervical dislocation under ether anesthesia and organs were excised for necropsy. Only non-pregnant female rates were used because of their more susceptible to biochemical compounds than male rats [20].
Subchronic oral administration of extract
The subchronic oral toxicity of the extract was carried out to determine the histopathological impact of A. spinosus roots on the vital organs of rats. The extract was administrated orally to rats in accordance to OECD guideline, Test No. 407 [21]. Rats weighing 150 ± 10 g, were divided into 3 groups of 10 (5 males; 5 females) and treated daily for 28 consecutive days. Group 1 and 2 received respectively A. spinosus extract at doses of 500 and 1000 mg/kg/day. Group 3 received only distilled water. The choice of doses of 500 and 1000 mg/kg bw was based on the therapeutic dose of A. spinosus which had been determined in our previous studies [3, 22]. Rats were observed daily for signs of toxicity during the experimental and body weight was recorded before gavage. Blood glucose levels were measured from the tail vein blood of rats prior fasted for 14 h, before and weakly using Accu-Chek Active glucometer, Germany. On day 29 of the end of treatment, the blood glucose levels were measured from the tail vein blood of rats prior fasted for. Then, rats were anesthetized with ether and blood was collected from the retroorbital sinus using a capillary tube. Blood was collected in hemolysis tubes for biochemical and in EDTA tubes for hematological parameters determination. Afterwards, rats were sacrificed by cervical dislocation under ether anesthesia and organs (liver, lungs, heart, spleen, brain, kidneys, testicles, ovaries) were excised for gross necropsy and weighed. The liver, spleen and kidneys were kept in formalin 10 % for histopathological studies. Biochemical and hematological analysis were performed respectively with Mindray BA-88 A Semi-Auto Chemistry Analyzer and URIT–5160 Auto Hematology Analyzer, China. Histological sections were exanimated under Olympus optical microscope equipped with a PC ocular camera, Germany.
Statistical analysis
Data of in vitro study were analysed by Microsoft Office Excel 2016. In vivo studies data were analysed by GraphPad Prism 6 software Inc., USA, and differences between groups were determined by one or two-ways ANOVA and considered statistically significant at p < 0.05. Value were expressed as mean ± standard error of mean (SEM).
Results
In vitro cytotoxicity of extract
All larvae used were viable (98.44 % in controls). A. spinosus root extract had a LC50 = 1.178 ± 0.021 mg/mL in brine shrimp larvae of Artemia salina. The extract also had a cutoff concentration of 0.39 mg/mL from which lethality began to be observed. The concentration 6.25 mg/mL was considered to be maximum because beyond this value no survivor was observed. In other words, the cytotoxicity of the extract was dose-dependent before reaching the peak at the dose of 6.25 mg/mL (Fig. 1).
Fig. 1
Toxicity of A. spinosus root extract in Artemia salina larvae. The shrimp larvae were incubated in seawater with extract for 24 h. After incubation, the survivors were counted and then the number of deaths was deducted. The data were analysed with Microsoft Office Excel 2016 software and expressed as the mean ± SEM. n = 3
×
Anzeige
Acute oral administration of extract
No mortality or clinical sign of toxicity were observed until the end of the 14 days of observation in female rats dosing by the dried hydroethanolic extract of A. spinosus roots at a single dose of 5000 mg/kg bw. All rats survived and no abnormalities were found in the organs at autopsy on day 15. According to the OECD limit test, the LD50 of A. spinosus root extract is higher than 5000 mg/kg by oral administration in rats.
Subchronic oral administration of extract
Effect of extract on body weight changes
Subchronic oral administration of the extract at doses of 500 and 1000 mg/kg for 28 consecutive days did not induce significant body weight gain in male and female rats over 4 weeks compared to controls (Figs.2 and 3).
Fig. 2
Effect of A. spinosus root extract on body weight changes in male rats. AS 500 & 1000 = A. spinosus 500 & 1000 mg/kg bw. Values were analysed with 1-ways ANOVA and then expressed as the mean ± SEM, compared to the control. n = 5
Fig. 3
Effect of A. spinosus root extract on body weight changes in female rats. AS 500 & 1000 = A. spinosus 500 & 1000 mg/kg bw. Values were analysed with 1-ways ANOVA and then expressed as the mean ± SEM, compared to the control. n = 5
×
×
Impact of the extract on organ weight
In male and female rats, no gross abnormalities or significant changes in organs were observed at autopsy of day 29 after subchronic oral administration extract at doses of 500 and 1000 mg/kg bw. All organs had a normal relative weight compared to controls. A. spinosus root extract did not cause significant changes of the value of relative organ weights (Figs. 4 and 5).
Fig. 4
Effect of A. spinosus root extract on relative organ weight in male rats. AS 500 & 1000 = A. spinosus 500 & 1000 mg/kg bw. Values were analysed with 1-ways ANOVA and then expressed as the mean ± SEM, compared to the control. n = 5
Fig. 5
Effect of A. spinosus root extract on relative organ weight in female rats. AS 500 & 1000 = A. spinosus 500 & 1000 mg/kg bw. Values were analysed with 1-ways ANOVA and then expressed as the mean ± SEM, compared to the control. n = 5
×
×
Effect of extract on basal blood glucose level
A. spinosus root extract at doses of 500 and 1000 mg/kg bw caused a decrease in basal blood glucose levels in rats during the 4 weeks of subchronic oral administration. The extract at doses of 500 and 1000 mg/kg bw caused a significant decrease (p < 0.01 to 0.0001) in basal blood glucose levels in male rats at the 1st, 2nd, 3rd and 4th week (Fig. 6). However, in female rats, subchronic oral administration of the two doses of extract caused a significant decrease (p < 0.05 and 0.001) in blood glucose levels at the 1st and 2nd week. The effect of A. spinosus root extract at doses of 500 and 1000 mg/kg bw was not significant in blood glucose levels decrease in female rats at the 3rd and 4th weak (Fig. 7).
Fig. 6
Effect of A. spinosus root extract on basal blood glucose levels in male rats. Blood glucose levels were measured before (W0) and weekly (W1; W2; W3 & W4) for 28 days. AS 500; 1000 = A. spinosus at doses of 500 and 1000 mg/kg bw. The values were analysed with 1-ways ANOVA and then expressed as the mean ± SEM. **p < 0.01; ***p < 0.001; ****p < 0.0001; compared to control. n = 5
Fig. 7
Effect of A. spinosus root extract on basal blood glucose levels in female rats. Blood glucose levels were measured before (W0) and weekly (W1; W2; W3 & W4) for 28 days. AS 500; 1000 = A. spinosus at doses of 500 and 1000 mg/kg bw. The values were analysed with 1-ways ANOVA and then expressed as the mean ± SEM. **p < 0.01; ***p < 0.001; ****p < 0.0001; compared to control. n = 5
×
×
Biochemical parameters
The biochemical parameters collected on day 29, did not reveal any signs of organ damage in treated groups at doses of 500 and 1000 mg/kg compared to controls. All parameters measured were normal in male rats (Table 1). However, the extract at a dose of 1000 mg/kg bw caused a significant (p < 0.05) decrease in total and LDL-cholesterol in female rats (Table 2).
Table 1
Effect of A. spinosus on biochemical parameters in male rats
Parameters
Control
A. spinosus
500 mg/kg/day
A. spinosus
1000 mg/kg/day
Urea (g/L)
0.369 ±0.041
0.338 ± 0.028
0.285 ± 0.044
Creatinine (mg/L)
6.762 ± 0.312
7.600 ± 0.303
7.320 ± 0.188
CPK (IU/L)
593.512 ± 53.677
535.358 ± 24.850
456.034 ± 58.569
ASAT (IU/L)
176.060 ± 8.968
159.600 ± 4.434
163.800 ± 6.248
ALAT (IU/L)
60.909 ± 4.186
60.200 ± 4.212
53.600 ± 5.344
ɣ-GT (IU/L)
7.100 ± 0.400
7.600 ± 0.678
8.200 ± 0.374
TG (g/L)
0.600 ± 0.079
0.572 ± 0.036
0.662 ± 0.055
TC (g/L)
0.683 ± 0.042
0.772 ± 0.028
0.726 ± 0.056
HDL-C (g/L)
0.379 ± 0.078
0.542 ± 0.032
0.470 ± 0.057
LDL-C (g/L)
0.207 ± 0.062
0.142 ± 0.015
0.150 ± 0.034
CPK = creatinine phosphokinase; ASAT = aspartate aminotransferase; ALAT = alanine aminotransferase; ɣ-GT = ɣ-glutamyltranspeptidase; TG = triglycerides; Total-C = total cholesterol; HDL and LDL-C = high and Low-density lipoprotein cholesterol. The values were analysed with 1-way ANOVA and expressed as the mean ± SEM, then compared to the control. n = 5
Table 2
Effect of A. spinosus on biochemical parameters in female rats
Parameters
Control
A. spinosus
500 mg/kg/day
A. spinosus
1000 mg/kg/day
Urea (g/L)
0.439 ±0.030
0.404 ± 0.030
0.390 ± 0.037
Creatinine (mg/L)
6.741 ± 0.692
7.980 ± 0.377
7.740 ± 0.060
CPK (IU/L)
331.867 ± 44.377
282.043 ± 40.296
272.058 ± 44.822
ASAT (IU/L)
160.011 ± 14.493
134.600 ± 6.071
135.400 ± 7.960
ALAT (IU/L)
50.796 ± 5.573
43.200 ± 3.734
46.200 ± 6.224
ɣ-GT (IU/L)
9.600 ± 1.400
8.000 ± 0.707
8.400 ± 0.678
TG (g/L)
0.732 ± 0.077
0.650 ± 0.070
0.748 ± 0.042
TC (g/L)
0.790 ± 0.040
0.680 ± 0.024
0.646 ± 0.038*
HDL-C (g/L)
0.492 ± 0.060
0.454 ± 0.045
0.470 ± 0.013
LDL-C (g/L)
0.192 ± 0.051
0.122 ± 0.046
0.056 ± 0.033*
CPK = creatinine phosphokinase; ASAT = aspartate aminotransferase; ALAT = alanine aminotransferase; ɣ-GT = ɣ-glutamyltranspeptidase; TG = triglycerides; Total-C = total cholesterol; HDL and LDL-C = high and Low-density lipoprotein cholesterol. The values were analysed with 1-way ANOVA and expressed as the mean ± SEM, then compared to the control. *p < 0.05. n = 5
Anzeige
Hematological parameters
28-day subchronic oral administration of A. spinosus root extract did not cause any significant change in erythropoiesis in treated groups compared to controls. All hematological parameters remained normal in rats of both sexes (Tables 3 and 4).
Table 3
Effect of A. spinosus root extract in hematological parameters in male rats
Parameters
Control
A. spinosus
500 mg/kg/day
A. spinosus
1000 mg/kg/day
RBC (106/µL)
6.736 ± 0.344
6.490 ± 0.096
6.464 ± 0.141
HGB (g/dL)
14.220 ± 0.767
13.700 ± 0.266
13.740 ± 0.225
HCT (%)
36.560 ± 2.345
35.480 ± 0.664
34.080 ± 0.661
MCV (fl.)
54.180 ± 0.840
54.660 ± 0.437
53.600 ± 0.896
MCH (pg)
21.480 ± 0.240
21.140 ± 0.125
21.520 ± 0.315
MCHC (g/dL)
39.500 ± 0.404
38.660 ± 0.201
40.160 ± 0.478
PLT (103/µL)
835.800 ± 137.764
836.800 ± 22.752
917.200 ± 92.566
WBC (103/µL)
4.300 ± 0.748
5.240 ± 0.564
3.060 ± 0.399
Neutrophils (%)
37.000 ± 3.302
42.800 ± 4.409
31.600 ± 3.600
Eosinophils (%)
3.200 ± 0.663
2.800 ± 0.735
3.400 ± 0.510
Basophils (%)
0.000 ± 0.000
0.000 ± 0.000
0.000 ± 0.000
Lymphocytes (%)
55.800 ± 1.985
49.600 ± 4.434
59.200 ± 3.583
Monocytes (%)
4.000 ± 1.342
4.800 ± 0.860
5.800 ± 0.860
RBC = red blood cells; HGB = hemoglobin; HCT = hematocrit; MCV = mean corpuscular volume; MCH = mean corpuscular hemoglobin; MCHC = mean corpuscular hemoglobin concentration; PLT = platelets; WBC = white blood cells. The values were analysed with 1-ways ANOVA and expressed as the mean ± SEM, then compared to controls. n = 5.
Table 4
Effect of A. spinosus root extract in hematological parameters in female rats
Parameters
Control
A. spinosus
500 mg/kg/day
A. spinosus
1000 mg/kg/day
RBC (106/µL)
61.70 ± 0.169
5.894 ± 0.109
6.090 ± 0.093
HGB (g/dL)
13.080 ± 0.280
12.440 ± 0.406
12.940 ± 0.340
HCT (%)
34.720 ± 0.878
32.780 ± 1.058
34.340 ± 1.375
MCV (fl.)
55.420 ± 0.828
55.520 ± 0.822
56.340 ± 1.451
MCH (pg)
20.900 ± 0.217
21.080 ± 0.340
21.240 ± 0.256
MCHC (g/dL)
37.740 ± 0.194
37.980 ± 0.547
37.780 ± 0.653
PLT (103/µL)
877.000 ± 120.557
916.200 ± 128.117
932.600 ± 65.472
WBC (103/µL)
4.000 ± 0.661
3.700 ± 0.633
3.160 ± 0.771
Neutrophils (%)
31.400 ± 6.250
33.200 ± 3.992
36.200 ± 5.826
Eosinophils (%)
1.800 ± 0.490
2.600 ± 0.510
3.000 ± 0.447
Basophils (%)
0.000 ± 0.000
0.000 ± 0.000
0.000 ± 0.000
Lymphocytes (%)
62.400 ± 7.089
59.600 ± 3.881
55.400 ± 5.715
Monocytes (%)
4.400 ± 1.691
4.600 ± 0.678
5.400 ± 0.510
RBC = red blood cells; HGB = hemoglobin; HCT = hematocrit; MCV = mean corpuscular volume; MCH = mean corpuscular hemoglobin; MCHC = mean corpuscular hemoglobin concentration; PLT = platelets; WBC = white blood cells. The values were analysed with 1-ways ANOVA and expressed as the mean ± SEM, then compared to the control. n = 5.
Histopathological studies
Microscopic examination of liver, spleen, and kidney sections of male and female rats, did not reveal any sign of toxicity or necrosis or the presence of inflammatory cells in tissues. Cell nuclei had also not been modified. All organ sections of treated and control groups were normal under microscopy (Figs. 8 and 9). Thus, subchronic oral administration of extract at doses of 500 and 1000 mg/kg did not cause any damage in the liver, spleen and kidneys in both sexes of rats.
Fig. 8
Histological section of the liver, spleen and kidneys of male rats. A. spinosus root extract was administered orally for 28 consecutive days. The autopsy was carried out on day 29 of the end of treatment. L-, S- and K-C = liver, spleen and kidney of control groups having received distilled water. L-, S-, K-AS 500 and 1000 = liver, spleen and kidney of test groups having received the extract of A. spinosus root at doses of 500 and 1000 mg/kg/day, respectively. Hematoxylin-eosin stain x100
Fig. 9
Histological section of the liver, spleen and kidneys of female rats. A. spinosus root extract was administered orally for 28 consecutive days. The autopsy was carried out on day 29 of the end of treatment. L-, S- and K-C = liver, spleen and kidney of control groups having received distilled water. L-, S-, K-AS 500 and 1000 = liver, spleen and kidney of test groups having received the extract of A. spinosus root at doses of 500 and 1000 mg/kg/day, respectively. Hematoxylin-eosin stain x100
×
×
Discussion
The safety assessment of A. spinosus roots showed that the dried hydroethanolic extract was non-toxic in animal health, either by contact or orally in single and repeated doses.
In brine shrimp larvae of Artemia salina, the LC50 of extract was > 0.1 mg/mL on the Mousseux scale [18]. Thus, the dried hydroethanolic extract of the roots of A. spinosus was considered to be non-cytotoxicity. The safety of A. spinosus in brine shrimp larvae has been demonstrated by other authors. Studies previously carried out by Khanal et al. [23] on the aerial part of A. spinosus showed that the hexanolic (LC50 = 0.237 mg/mL), chloroform (LC50 = 0.195 mg/mL) and aqueous (LC50 = 0.321 mg/mL) extracts showed non-cytotoxicity in Artemia salina larvae. Only ethanolic extract (LC50 = 0.032 mg/mL) showed moderate cytotoxicity. Otherwise, Octaviani et al. [24] found that the ethanolic extract of the leaves of A. spinosus had a LC50 > 0.140 mg/mL (which was > 0.1 mg/mL) and considered non-toxic on the Mousseux scale [18].
Anzeige
A single oral administration of the dried hydroethanolic extract of A. spinosus root at a dose of 5000 mg/kg bw did not result in any mortality or clinical sign of toxicity in dosed female rats during the 24 h and 14 days of observation. No abnormality was found in the organs at autopsy on day 15 and mean that A. spinosus root extract was non-toxic for oral administration with a LD50 > 5000 mg/kg bw. The extract of A. spinosus roots can therefore be administered at doses < 5000 mg/kg bw.
No mortality or sign of toxicity was found at the end of the experiment in male and female rats treated with the extract at doses of 500 and 1000 mg/kg bw. No significant change in body weight or organ weight were found in gross autopsy. This was confirmed by histopathological examination where sections of the liver, spleen and kidneys of rats treated at doses of 500 and 1000 mg/kg of extract showed no sign of injury. Hematological parameters which allow detection of anemia, thrombosis and alterations in the immune system, did not reveal any significant change either. Therefore, the extract does not cause anemia, blood clotting disorder, or symptoms related to the immune system. Renal (urea, creatinine), hepatic (ALAT, ASAT, ɣ-GT) and cardiac (CPK) markers showed no sign of damage to these organs. The lipid (TG, TC, HDL-C and LDL-C) markers also revealed no sign of predisposition to atherosclerosis and myocardial infarction. The significant (p < 0.05) decrease in total cholesterol and LDL-cholesterol observed in female rats treated by extract at a dose of 1000 mg/kg bw showed that the root of A. spinosus can be used to manage dyslipidemia and prevent cardiovascular diseases [25, 26]. These results are consistent with other previous studies. When evaluating the effect of the leaf extract of A. spinosus on biochemical parameters in rats, Akinloye and Olorede [27] showed no significant change in ALT and ASAT in the treated groups compared to controls. However, Bhande and wasu [15] showed a significant decrease in total cholesterol, ASAT, ALAT, urea and triglycerides at the end of day 60 of oral administration of aqueous extract of whole plants of A. spinosus at doses of 500 and 1000 mg/kg bw. This could be explained by the type of plant organ used, the type of extract and especially the duration of subchronic administration. Akinloye and Olorede [27] reported no significant change in hematological parameters. However, Bhande and Wasu [16], when assessed hematological parameters over a 60-day period of oral administration of aqueous extract of whole plant at a dose of 1000 mg/kg bw in male albino Wistar rats, found a significant decrease in red blood cells and hemoglobin; and increase in white blood cells. This suggests that the change in hematological parameters after oral administration of A. spinosus may depend to the method of extraction and the duration of treatment.
In this study, a significant (p < 0.5 to 0.001) decrease in basal blood glucose level was observed in male and female rats treated with A. spinosus extract at doses of 500 and 1000 mg/kg bw during the 4 weeks. This decrease in basal blood glucose level in rats was in accordance with the hypoglycemic effect of the plant and could be due to phytochemicals such as flavonoids demonstrated in our previous study [3].
The in vitro and in vivo studies demonstrated that A. spinosus roots extract was non-toxic in animal health. The significant decrease in blood glucose level observed during the experiment was not correlated with any biochemical and hematological parameters or associated with any abnormality in the liver and kidneys in gross autopsy and in histopathological examination. Therefore, the dried hydroethanolic extract of A. spinosus roots can be consider safe in animal health when use for cutaneous and oral administration.
Conclusions
This study proved the safety of the dried hydroethanolic extract of Amaranthus spinosus root extract in Artemia salina larvae and rats. No cytotoxicity effect of extract was found in acute toxicity in brine shrimp larvae during the 24 h. Furthermore, oral administration of A. spinosus root extract in a single and in repeated doses for 28 consecutive days, did not cause any mortality or obvious symptoms of toxicity in male and female rats. Biochemical, hematological and histopathological studies also did not show any significant change or sign of toxicity other than the observed decrease in blood glucose level. However, this decrease in blood glucose level was not correlated with any organ damage. Thus, the dried hydroethanolic extract of A. spinosus roots at doses ≤ 1000 mg/kg bw could be considered safe and used for cutaneous and oral administration without histopathological impact. However, further studies such as embryo/fetotoxicity, genotoxicity and neurotoxicity will be needed to prove the safety of chronic administration of the extract in patients and fetuses.
Acknowledgements
Not applicable.
Declarations
Ethics approval and consent to participate
All experiments in animals were performed in compliance with the institutional guidelines of the Laboratory of Physiology-Pharmacology, University of Lome (Togo) (001/2012/CB-FDS-UL) and approved by the National Ethics Committee.
Consent for publication
Not applicable.
Competing interests
The author declare that they have no competing interest.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
